Institut National d'Oncologie
In research, Institut National d'Oncologie stands highest in Medicine (#9,967 of 10,443 worldwide) and Health Sciences (#11,564 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Surgery — Surgery is 6.5× its share of world research.
- World rank, 2022–2025
- #26,267 of 28,054 · #37,091 all time
- Rank in Morocco
- #55 of 59
- Research works
- 852 ▼ 38% vs 2013–17
- Citations
- 4.3k 5.1 per fractional work
- Top-10% rate
- 3.6% record average 16.5%
- Open access
- 45% world 28%
What is Institut National d'Oncologie known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #9,967 of 10,443 | 2.1% | 111 | #12792 | |
| Health SciencesDomain | #11,564 of 11,982 | 2.3% | 120 | #15741 |
Each strip is that field’s whole ranked pool, with the notch where Institut National d'Oncologie sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Institut National d'Oncologie specialise in?
Where its research is concentrated relative to its size: Surgery takes 6.5× the share of its output that it takes of world research.
- SurgerySubfield · 22.0 works6.5×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Dentistry, 4.1×. Every wedge is a field page.
- Dentistry 4.1×
- Medicine 4.0×
- Health Professions 1.4×
- Economics, Econometrics and Finance 1.2×
- Biochemistry, Genetics and Molecular Biology 1.0×
- Nursing 0.7×
- Immunology and Microbiology 0.7×
- Decision Sciences 0.3×
- Agricultural and Biological Sciences 0.3×
- Neuroscience 0.3×
- Earth and Planetary Sciences 0.3×
- Physics and Astronomy 0.2×
- Business, Management and Accounting 0.2×
- Computer Science 0.2×
- Social Sciences 0.1×
- Energy 0.1×
- Chemistry 0.1×
- Engineering 0.1×
- Pharmacology, Toxicology and Pharmaceutics 0.1×
- Environmental Science 0.1×
- Materials Science 0.0×
Who are the top researchers at Institut National d'Oncologie?
Ranked on the composite score, I. Chami, Hind Mrabti and N. Benjaafar lead among researchers whose main affiliation is Institut National d'Oncologie.
- 1 I. Chami Morocco · #703,894 worldwide 30 citations · 19 works
- 2 Hind Mrabti Morocco · #895,832 worldwide 32 citations · 31 works
- 3 N. Benjaafar Morocco · #1,165,394 worldwide 3 citations · 17 works
- 4 Hassan Errihani Morocco · #1,206,645 worldwide 27 citations · 87 works
- 5 Sanae Amalik Morocco · #1,335,603 worldwide 0 citations · 20 works
- 6 B.K. El Gueddari Morocco · #1,345,794 worldwide 3 citations · 18 works
- 7 Tayeb Kebdani Morocco · #1,373,100 worldwide 6 citations · 69 works
- 8 Youssef Omor Morocco · #1,383,024 worldwide 5 citations · 30 works
- 9 Rachida Latib Morocco · #1,413,479 worldwide 3 citations · 49 works
- 10 Noureddine Benjaafar Morocco · #1,419,509 worldwide 7 citations · 41 works
Which keywords describe research at Institut National d'Oncologie?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Prognostic Factors, Radiotherapy, Surgical Management, Immunotherapy, Clinical Practice Guidelines, Immunohistochemistry and Genetic Mutations.
- Human Papillomavirus
- Molecular Pathology
- Survival
- Population-Based Study
- Cetuximab
- Breast Cancer
- Cancer Incidence
- Neoadjuvant Therapy
- Squamous Cell Carcinoma
- Cancer Survivorship
- Molecular Profiling
- Treatment
- Clinical Trials
- Prognosis
- Metastasis
- Immunohistochemistry
- Clinical Practice Guidelines
- Immunotherapy
- Radiotherapy
- Prognostic Factors
- Chemotherapy
- Epidemiology
- Surgical Management
- Quality of Life
- Genetic Mutations
- Survival Analysis
- Radiation Therapy
- Molecular Classification
- Diagnosis
- Clinical Management
- Risk Factors
- Gene Expression Profiling
- Diagnostic Algorithm
- Surgery
- Health-related Quality of Life
- Cancer of Unknown Primary
- Chemoradiotherapy
- Tissue of Origin
- Targeted Therapy
- Palliative Treatment
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy17▲ 17×20 topics
- Prognostic Factors13▲ 21×12 topics
- Epidemiology12▲ 2.0×27 topics
- Radiotherapy12▲ 21×10 topics
- Surgical Management9▲ 15×11 topics
- Immunotherapy9▲ 8.9×12 topics
- Quality of Life9▲ 4.3×13 topics
- Clinical Practice Guidelines9▲ 11×9 topics
- Genetic Mutations8▲ 13×12 topics
- Immunohistochemistry8▲ 79×4 topics
- Survival Analysis7▲ 18×6 topics
- Metastasis7▲ 14×6 topics
- Radiation Therapy6▲ 34×5 topics
- Prognosis6▲ 13×4 topics
- Molecular Classification6▲ 27×4 topics
- Clinical Trials6▲ 6.0×8 topics
- Diagnosis6▲ 4.2×14 topics
- Treatment6▲ 3.2×14 topics
- Clinical Management5▲ 21×5 topics
- Molecular Profiling5▲ 37×3 topics
- Risk Factors5▲ 3.0×6 topics
- Cancer Survivorship5▲ 43×2 topics
- Gene Expression Profiling4▲ 38×2 topics
- Squamous Cell Carcinoma4▲ 33×3 topics
- Diagnostic Algorithm4▲ 62×2 topics
- Neoadjuvant Therapy4▲ 12×5 topics
- Surgery4▲ 8.1×6 topics
- Cancer Incidence4▲ 20×4 topics
- Health-related Quality of Life4▲ 12×3 topics
- Breast Cancer4▲ 11×8 topics
- Cancer of Unknown Primary4▲ 96×1 topic
- Cetuximab4▲ 31×2 topics
- Chemoradiotherapy4▲ 51×2 topics
- Population-Based Study4▲ 40×2 topics
- Tissue of Origin4▲ 96×1 topic
- Survival4▲ 18×4 topics
- Targeted Therapy4▲ 11×4 topics
- Molecular Pathology3▲ 22×3 topics
- Palliative Treatment3▲ 35×2 topics
- Human Papillomavirus3▲ 18×3 topics
Which research topics does Institut National d'Oncologie publish most on?
By volume in 2022–2025: Cancer Diagnosis and Treatment, Cancer and Skin Lesions, Cancer survivorship and care and Bone Tumor Diagnosis and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Diagnosis and Treatment Oncology 4 works
- 2 Cancer and Skin Lesions Dermatology 3 works
- 3 Cancer survivorship and care Oncology 3 works
- 4 Bone Tumor Diagnosis and Treatments Rheumatology 3 works
- 5 Soft tissue tumor case studies Rheumatology 3 works
- 6 Oral and Maxillofacial Pathology Oral Surgery 3 works
- 7 Head and Neck Cancer Studies Otorhinolaryngology 3 works
- 8 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 2 works
- 9 Salivary Gland Tumors Diagnosis and Treatment Surgery 2 works
- 10 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institut National d'Oncologie's research output changed?
Output in 2018–2022 was 38% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rabat
- Mohammed V University
- Institut National de la Recherche Agronomique
- Centre Hospitalier Ibn Sina
- Centre National pour la Recherche Scientifique et Technique (CNRST)
- Ecole Mohammadia d'Ingénieurs
- Institut Agronomique et Vétérinaire Hassan II
- Institut National des Postes et Télécommunications
- Instituts Supérieurs des Professions Infirmières et Techniques de Santé
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.